Schimmel Paul's Form 4 filing
aTYR PHARMA INC (ATYR) · filed Jul 24, 2024
- Accession no.
- 0000950170-24-086159
- Filed
- Jul 24, 2024
- Trade date
- Jul 22-24, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $184.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schimmel PaulCIK 0001236447 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | PPurchaseAcquired | +41,052 | $1.74 | +$71,430.48 | 354,075 | Indirect | |
| Jul 23, 2024 | Common Stock | PPurchaseAcquired | +6,648 | $1.82 | +$12,099.36 | 360,723 | Indirect | |
| Jul 24, 2024 | Common Stock | PPurchaseAcquired | +52,300 | $1.93 | +$100,939 | 413,023 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.